Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hisanori Shimizu
Observed names:
H Shimizu,
HISANORI SHIMIZU,
Hisanori SHIMIZU,
SHIMIZU HISANORI,
Shimizu, Hisanori
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
SHOWA Medical University,
St. Luke's International Hospital,
The Cancer Institute Hospital,
SHOWA Medical University Hospital,
Japanese Foundation For Cancer Research,
International University of Health and Welfare
show all 6
ORCID:
0000-0002-5623-6464
Observed ORCID:
0000-0002-5623-6464
OpenAlex ID:
A5101446570
Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy
2015
·
Shuichi Yajima
, Hisanori Shimizu
, et al.
·
BMC Health Services Research
·
23
PDF
[Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis].
1993
·
T Hirota
, T Honjo
, et al.
·
PubMed
·
19
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer
2017
·
Nao Tagawa
, Erika Sugiyama
, et al.
·
Cancer Chemotherapy and Pharmacology
·
16
Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
2018
·
Hisanori Shimizu
, Kenichi Suzuki
, et al.
·
Journal of Pharmaceutical Health Care and Sciences
·
13
PDF
Cost-Utility Analysis of the Oral Fluoropyrimidine S-1 Versus Conventional Intravenous Chemotherapy in Advanced or Recurrent Gastric Cancer
2009
·
Hiroyuki Sakamaki
, Shunya Ikeda
, et al.
·
The Open Health Services and Policy Journal
·
8
PDF
Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study
2024
·
Yuma Nonomiya
, Izuma Nakayama
, et al.
·
Biological and Pharmaceutical Bulletin
·
6
PDF
Utility-based Evaluation of the Quality of Life of Patient's with Gastric Cancer Who Receive Chemotherapy-Comparison of Patients' Quality of Life between Oral TS-1 and Conventional Injectable Combination Therapy-
2008
·
Hisanori SHIMIZU
, Katsumi TANAKA
, et al.
·
YAKUGAKU ZASSHI
·
6
PDF
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].
1993
·
T Hirota
, T Honjo
, et al.
·
PubMed
·
6
Community pharmacists' measurement of health-related quality of life in outpatients taking high-risk drugs
2022
·
Takenori Ichimura
, Chiaki Ogawa
, et al.
·
Die Pharmazie
·
5
PDF
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
2023
·
KOKI HASHIMOTO
, KAZUYOSHI KAWAKAMI
, et al.
·
Anticancer Research
·
4
PDF
Assessment of Injection Site Reactions for Peripheral Intravenous Oxaliplatin Infusion and Potential Remedies.
2016
·
Satoko Handa
, Ryohei Kuroiwa
, et al.
·
PubMed
·
4
[Comparative trial of granisetron versus granisetron plus methylprednisolone for the prevention of nausea and vomiting induced by cancer chemotherapy].
1994
·
T Hirota
, H Shimizu
, et al.
·
PubMed
·
4
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
2023
·
Yoshikazu Tateai
, Kazuyoshi Kawakami
, et al.
·
PLoS ONE
·
3
PDF
Community pharmacists’ measurement of health-related quality of life for breast cancer with positive hormone receptors: A prospective observational study
2023
·
Takenori Ichimura
, Hisanaga Nomura
, et al.
·
SAGE Open Medicine
·
3
Factors Affecting Delayed Recovery from Neutropenia in Patients with pancreatic Cancer Receiving Gemcitabine Plus Nab-Paclitaxel
2025
·
Naoko Yoshida
, Shungo Imai
, et al.
·
Journal of Cancer
·
2
PDF
Development of a New Cleaning Method for Anticancer Drug Preparation Areas: Verification of the Substance Removal Effect of Cyclophosphamide by Electrolyzed Water
2025
·
Hisanori Shimizu
, Hiromu Tanigawa
, et al.
·
BPB Reports
·
2
PDF
Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study
2024
·
Takuya Tomomatsu
, Hisanori Shimizu
, et al.
·
YAKUGAKU ZASSHI
·
2
PDF
Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy
2022
·
NAOKI SHIBATA
, KAZUYOSHI KAWAKAMI
, et al.
·
Anticancer Research
·
2
Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
2026
·
YUKA KIMURA
, KAZUYOSHI KAWAKAMI
, et al.
·
Anticancer Research
·
1
Postoperative liver dysfunction in gastric cancer patients following early enhanced nutritional protocols: a retrospective observational study
2025
·
Kazuo Kobayashi
, Satoshi Ida
, et al.
·
Journal of Pharmaceutical Health Care and Sciences
·
1
Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients
2025
·
Koki Hashimoto
, Takashi Yokokawa
, et al.
·
Oncology
·
1
Removal efficiency of antineoplastic drug cyclophosphamide by hypochlorous acid
2024
·
Yusuke Iwasaki
, Makoto Hiraide
, et al.
·
Journal of Occupational and Environmental Hygiene
·
1
Evaluation of the Leftover Capecitabine Tablets in Adjuvant CAPOX Chemotherapy for Gastric Cancer
2023
·
Yuka Kimura
, Kazuyoshi Kawakami
, et al.
·
YAKUGAKU ZASSHI
·
1
PDF
Cost-minimization Analysis of S-1 Plus Irinotecan (IRIS) versus Oxaliplatin or Irinotecan Plus Fluorouracil and Folinic Acid (mFOLFOX6 or FOLFIRI) in Patients with Advanced Colorectal Cancer
2015
·
Hisanori Shimizu
, Shunya Ikeda
, et al.
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
·
1
PDF
[Provision of information by pharmacists regarding the effective timing of co-administration of first-generation serotonin receptor antagonists and dexamethasone for chemotherapy-induced nausea and vomiting in patients receiving Doxorubicin and cyclophosphamide chemotherapy for breast cancer].
2012
·
Hisanaga Nomura
, Hideyasu Kawakami
, et al.
·
PubMed
·
1
Show more works
View as search
Works count:
43
Citation count:
136
H-index:
6
I10-index:
4
Year
Topic
Type